awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36542583-B37619B1-8873-4EAA-9ACA-97D08DAE6FBB
Q36542583-B37619B1-8873-4EAA-9ACA-97D08DAE6FBB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36542583-B37619B1-8873-4EAA-9ACA-97D08DAE6FBB
Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis
P2860
Q36542583-B37619B1-8873-4EAA-9ACA-97D08DAE6FBB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36542583-B37619B1-8873-4EAA-9ACA-97D08DAE6FBB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0fb7a84e50171ca2b16a638042a7c896325cfe9c
P2860
A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.